CO2024010803A2 - Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico - Google Patents

Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico

Info

Publication number
CO2024010803A2
CO2024010803A2 CONC2024/0010803A CO2024010803A CO2024010803A2 CO 2024010803 A2 CO2024010803 A2 CO 2024010803A2 CO 2024010803 A CO2024010803 A CO 2024010803A CO 2024010803 A2 CO2024010803 A2 CO 2024010803A2
Authority
CO
Colombia
Prior art keywords
thienopyrrolotriazine
compounds
preparation
therapeutic use
formula
Prior art date
Application number
CONC2024/0010803A
Other languages
English (en)
Spanish (es)
Inventor
Olivier Arnoud
Franck Caussanel
Rommel Dadji-Faihun
Gwladys Langot
Frank Marguet
Olivier Venier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of CO2024010803A2 publication Critical patent/CO2024010803A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CONC2024/0010803A 2022-02-21 2024-08-08 Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico CO2024010803A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22315036 2022-02-21
PCT/EP2023/054138 WO2023156643A1 (en) 2022-02-21 2023-02-20 Thienopyrrolotriazine compounds, their preparation and their therapeutic use

Publications (1)

Publication Number Publication Date
CO2024010803A2 true CO2024010803A2 (es) 2024-08-20

Family

ID=81326677

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2024/0010803A CO2024010803A2 (es) 2022-02-21 2024-08-08 Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico

Country Status (11)

Country Link
US (1) US20250129091A1 (cg-RX-API-DMAC7.html)
EP (1) EP4482841B1 (cg-RX-API-DMAC7.html)
JP (1) JP2025506729A (cg-RX-API-DMAC7.html)
KR (1) KR20240151767A (cg-RX-API-DMAC7.html)
CN (1) CN118843632A (cg-RX-API-DMAC7.html)
AU (1) AU2023222186A1 (cg-RX-API-DMAC7.html)
CA (1) CA3244475A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024010803A2 (cg-RX-API-DMAC7.html)
IL (1) IL314781A (cg-RX-API-DMAC7.html)
MX (1) MX2024010216A (cg-RX-API-DMAC7.html)
WO (1) WO2023156643A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116375728B (zh) * 2021-12-31 2025-06-10 成都赜灵生物医药科技有限公司 噻吩吡咯并三嗪酮类化合物及其用途
TW202545527A (zh) 2024-01-16 2025-12-01 英商諾得瑟拉公司 Nlrp3及glp-1a組合療法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12168012B2 (en) * 2018-07-25 2024-12-17 Novartis Ag NLRP3 inflammasome inhibitors
US20230203064A1 (en) * 2020-04-23 2023-06-29 Janssen Pharmaceutica Nv Tricyclic compounds as inhibitors of nlrp3

Also Published As

Publication number Publication date
EP4482841A1 (en) 2025-01-01
AU2023222186A1 (en) 2024-10-10
MX2024010216A (es) 2024-09-02
CA3244475A1 (en) 2023-08-24
CN118843632A (zh) 2024-10-25
WO2023156643A1 (en) 2023-08-24
JP2025506729A (ja) 2025-03-13
KR20240151767A (ko) 2024-10-18
EP4482841B1 (en) 2026-07-15
US20250129091A1 (en) 2025-04-24
IL314781A (en) 2024-10-01

Similar Documents

Publication Publication Date Title
UY38793A (es) Compuestos químicos
MX2022005839A (es) Compuestos utiles como inhibidores de la proteina helios.
CL2024002183A1 (es) Compuestos de benzopirimidina y usos de estos
PY1923494A (es) Derivados de n-(3-(7h-pirrolo[2,3-d]pirimidin-4-il)fenil)benzamida
CR20220251A (es) Nuevos derivados de metilquinazolinona
BR112022002496A2 (pt) Compostos deuterados para uso no tratamento de câncer
UY27381A1 (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
CO2021004789A2 (es) Piridazinonas y sus métodos de uso
BR112022003982A2 (pt) Compostos heterocíclicos
CY1112453T1 (el) Αντιϊικες ενωσεις
MX2023007265A (es) Inhibidores de cdk y su uso como productos farmacéuticos.
CO2023000056A2 (es) Derivados de amidopirimidona
BR112022003357A2 (pt) Compostos heterocíclicos
BR122019010008B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
MX2022001449A (es) Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos.
MX2024010216A (es) Compuestos de tienopirrolotriazina, su preparacion y su uso terapeutico.
MX2023004955A (es) Compuestos de aminotiazol deuterados como compuestos antiviricos.
CL2025002125A1 (es) Compuestos novedosos
CO2025012210A2 (es) Polimorfo como inhibidor de la proteína quinasa mek, método de preparación y uso del mismo
DOP2026000099A (es) Nuevos compuestos
CL2024001073A1 (es) Inhibidores de la replicación del virus de inmunodeficiencia humana
MX2023000727A (es) 4-furanamidas y procedimiento para su preparacion.
BR112021025317A2 (pt) Tienilhidroxiisoxazolinas e derivados das mesmas
EA200602281A1 (ru) Гетероарилсульфоны и сульфонамиды и их терапевтические применения
MX2025000791A (es) Compuestos terapeuticos, formulaciones y uso de los mismos